Latest News about NVO
Recent news which mentions NVO
CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
March 14, 2025
From Benzinga
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
March 14, 2025
From Benzinga
The Motley Fool's Market Volatility Toolkit
March 13, 2025
From Motley Fool
EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity
March 13, 2025
From Benzinga
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
March 12, 2025
From Motley Fool
Why Hims & Hers Health Stock Just Popped
March 11, 2025
From Motley Fool
Top 3 Health Care Stocks That May Keep You Up At Night In Q1
March 11, 2025
From Benzinga
Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial
March 11, 2025
From Benzinga
From Motley Fool
From Motley Fool
Is Eli Lilly Stock a Buy?
March 11, 2025
From Motley Fool
The State of Weight Loss Drugs
March 10, 2025
From Motley Fool
3 Cold Stocks That Can Bounce Back This Week
March 10, 2025
From Motley Fool
Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 10, 2025
From Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
March 06, 2025
From Benzinga
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
March 06, 2025
From Benzinga
From Motley Fool
Why Is Hims & Hers Health Stock Trading Lower On Wednesday?
March 05, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
NVO
From Motley Fool
Why Hims & Hers Stock Rebounded on Wednesday
February 26, 2025
From Motley Fool
6 Stocks to Buy as European Markets Soar
February 26, 2025
From Benzinga
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
From Benzinga
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
February 24, 2025
From Motley Fool
From Benzinga
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
February 23, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.